COMMUNIQUÉS West-GlobeNewswire

Chembio Ebola Virus Diagnostic Test Receives U.S. FDA Emergency Use Authorization

09/11/2018 - 17:14

MEDFORD, N.Y., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care ("POC") diagnostics company focused on infectious diseases, today announced the receipt of U.S. Food and [...]

Gradalis® Presents Initial Data from Phase II U.S. Trial for Ewing’s sarcoma at the Annual Meeting of the Children’s Oncology Group

09/11/2018 - 16:04

DALLAS, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Gradalis, Inc., a clinical-stage immunotherapy company developing investigational treatments for individuals suffering from multiple cancer indications, presented initial data [...]

Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2019

09/11/2018 - 15:31

DUBLIN - November 9, 2018 - Medtronic plc (NYSE:MDT) announced today that it will report financial results for the second quarter of fiscal year 2019 on Tuesday, November 20, 2018. A news release will be issued at [...]

Next Green Wave’s Unique Business Model Yields Greater Potential -- CFN Media

09/11/2018 - 15:00

SEATTLE, Nov. 09, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

iCAD Announces Retirement of CEO, Ken Ferry

09/11/2018 - 14:53

Michael Klein, Chairman of the Board, to serve as Executive Chairman and Interim CEO NASHUA, N.H., Nov. 09, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative [...]

Novelion Therapeutics Reports Third Quarter 2018 Financial Results

09/11/2018 - 14:46

VANCOUVER, British Columbia, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN), a biopharmaceutical company dedicated to developing and commercializing therapies for individuals living with [...]

NICE publishes advice on gammaCore for the treatment of cluster headache in the UK

09/11/2018 - 14:40

Report contributors agreed gammaCore was highly innovative, may be more effective than standard of care alone, and has the potential to save money through the NHS by reducing the cost of treating cluster headache [...]

Ultragenyx to Present at Upcoming Investor Conferences

09/11/2018 - 14:30

NOVATO, Calif., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases [...]

Hemostemix Announces Development of an ACP-01 Allogeneic Process and Initiation of R&D for Autologous NCP-01 Neural Cellular Precursors

09/11/2018 - 14:30

CALGARY, Alberta, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to provide the following update on its research and development [...]

Caladrius Biosciences to Participate in the Inv€$tival Showcase in Partnership with Jefferies and the Jefferies 2018 London Healthcare Conference

09/11/2018 - 14:30

Basking Ridge, NJ, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences to Participate in the Inv€$tival Showcase in Partnership with Jefferies and the Jefferies 2018 London Healthcare Conference BASKING RIDGE, N.J [...]

Kane Biotech Records Significant Online Sales Growth from Amazon

09/11/2018 - 14:30

349% Year-over-Year Growth in October YTD Sales WINNIPEG, Manitoba, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”), today announced that it has [...]

Cytori to Webcast Third Quarter Financial Results on November 14

09/11/2018 - 14:30

SAN DIEGO, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) will provide a live webcast of its third quarter financial results and business update on Wednesday, November 14, 2018 at 5:30 PM [...]

SELLAS Life Sciences Announces Settlement of Counterclaims Against JGB (Cayman) Newton, Ltd. for $6.6 Million Payment by JGB

09/11/2018 - 14:30

Follows Dismissal by Court of All Claims Against SELLAS Debenture and All Security Interests Held by JGB Terminated NEW YORK, Nov. 09, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq:SLS) (“SELLAS” or [...]

Chr. Hansen A/S - Major shareholder announcement from Novo Holdings A/S and Novo Nordisk Fonden

09/11/2018 - 14:20

Company Announcement No. 23/2018 November 9, 2018 For further information please contact: Martin Riise, Senior Director, Investor Relations, Tel: +45 5339 2250 Camilla Lercke, Head of Media Relations, Tel: +45 5339 2384 [...]

Stryker completes acquisition of K2M

09/11/2018 - 14:10

Kalamazoo, Michigan, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) has completed the previously announced acquisition of K2M Group Holdings, Inc., a global leader of complex spine and minimally invasive solutions [...]

Atea Pharmaceuticals to Present Positive Clinical Data with At-527 for the Treatment of Chronic Hepatitis C in Patients with Cirrhosis at The Liver Meeting ® 2018

09/11/2018 - 14:01

AT-527 is a novel pan-genotypic purine nucleotide prodrug NS5B polymerase inhibitor AT-527 shows profound and equivalent pan-genotypic antiviral activity in cirrhotic and non-cirrhotic (NC) hepatitis C virus (HCV) [...]

Celldex Presents Promising Interim Data from Phase 1 Study of Differentiated CD40 Agonist CDX-1140 at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting

09/11/2018 - 14:01

--Well tolerated; dose dependent biological effects consistent with CD40-mediated immune cell activity-- --Program development expanded based on results observed to date-- HAMPTON, N.J., Nov. 09, 2018 (GLOBE NEWSWIRE [...]

Achaogen Announces Presentations at Two Investor Healthcare Conferences in November

09/11/2018 - 14:01

SOUTH SAN FRANCISCO, Calif., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug [...]

Neon Therapeutics Presents Updated Data at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting

09/11/2018 - 14:00

– Management Hosting Webcast of Key Opinion Leader Discussion Today at 6:00 p.m. ET – CAMBRIDGE, Mass., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company [...]